NAROPIN is a Epidural; Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by General Injectables & Vaccines, Inc. The primary component is Ropivacaine Hydrochloride.
| Product ID | 52584-286_18b9c3f9-6ebf-4dcb-a5fd-5ac424f6ab0b |
| NDC | 52584-286 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NAROPIN |
| Generic Name | Ropivacaine Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | EPIDURAL; INFILTRATION; PERINEURAL |
| Marketing Start Date | 2014-03-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020533 |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-03-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020533 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-03-11 |
| Ingredient | Strength |
|---|---|
| ROPIVACAINE HYDROCHLORIDE | 5 mg/mL |
| SPL SET ID: | 096c2693-8488-48c2-88ee-bf3df95c3f4c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-9924 | NAROPIN | ropivacaine hydrochloride |
| 52584-286 | NAROPIN | NAROPIN |
| 63323-285 | Naropin | Naropin |
| 63323-286 | Naropin | Naropin |
| 63323-287 | Naropin | Naropin |
| 63323-288 | Naropin | Naropin |
| 0143-9263 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 0143-9264 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 0143-9265 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 0143-9266 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE |
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE |
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE |
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE |
| 0781-3140 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 0781-3142 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 17478-081 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 17478-082 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride |
| 25021-652 | ropivacaine hydrochloride | ropivacaine hydrochloride |
| 25021-653 | Ropivacaine Hydrochloride | ropivacaine hydrochloride |
| 25021-671 | ropivacaine hydrochloride | ropivacaine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NAROPIN 78276844 not registered Dead/Abandoned |
AstraZeneca AB 2003-07-21 |
![]() NAROPIN 75229359 2130448 Live/Registered |
FRESENIUS KABI USA, LLC 1997-01-22 |
![]() NAROPIN 75085662 2148189 Live/Registered |
FRESENIUS KABI USA, LLC 1996-04-09 |
![]() NAROPIN 74716292 not registered Dead/Abandoned |
ASTRA AKTIEBOLAG 1995-08-16 |
![]() NAROPIN 74581013 2061834 Dead/Cancelled |
ABRAXIS BIOSCIENCES, INC. 1994-10-03 |
![]() NAROPIN 74157414 not registered Dead/Abandoned |
AKTIEBOLAGET ASTRA 1991-04-12 |